EPISODE · Jun 23, 2022 · 4 MIN
Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors
from The Journal of Clinical and Aesthetic Dermatology · host JCAD
Send us Fan MailLisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own patients. Dr. Swanson then outlines things to consider before starting patients on JAK inhibitors.
Embed this episode
Ready to play
Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.